Abstract Throughout Southeast Asia, repressive drug laws have resulted in high rates of imprisonment in people who inject drugs (PWID) and people living with HIV (PLH), greatly magnifying the harm associated with HIV, tuberculosis, and addiction. We review findings from Malaysia's largest prison to describe the negative synergistic effects of HIV, tuberculosis, addiction, and incarceration that contribute to a 'perfect storm' of events challenging public and personal health and offer insights into innovative strategies to control these converging epidemics. The majority of PLH who are imprisoned in Malaysia are opioid dependent PWID. Although promoted by official policy, evidence-based addiction treatment is largely unavailable, contributing to rapid relapse and/or overdose after release. Similarly, HIV treatment in prisons and compulsory drug treatment centers is sometimes inadequate or absent. The prevalence of active tuberculosis is high, particularly in PLH, and over 80 % of prisoners and prison personnel are latently infected. Mandatory HIV testing and subsequent segregation of HIV-infected prisoners increases the likelihood of tuberculosis acquisition and progression to active disease, amplifying the reservoir of infection for other prisoners. We discuss strategies to control these intersecting epidemics including screening linked to standardized treatment protocols for all three conditions, and effective transitional programs for released prisoners. For example, recently introduced evidencebased interventions in prisons like antiretroviral therapy (ART) to treat HIV, isoniazid preventive therapy to treat latent tuberculosis infection, and methadone maintenance to treat opioid dependence, have markedly improved clinical care and reduced morbidity and mortality. Since introduction of these interventions in September 2012, all-cause and HIVrelated mortality have decreased by 50.0 % and 75.7 %, respectively. We discuss the further deployment of these interventions in Malaysian prisons.
Introduction
In Asia, over 3.89 million people are currently detained in prisons and jails (Walmsley 2016) and an additional 635, 000, perhaps more, are held in compulsory drug detention centers (CDDCs) (Kamarulzaman and McBrayer 2015; Tanguay et al. 2015) . Criminal justice settings are dynamic, with up to 30 million persons released from prisons worldwide each year (Kinner and Wang 2014) . Incarceration rates in Asia (excluding China and India) increased 37.6 % from 2000 to 2015, compared to a 17.5 % increase in Asian national populations during the same period (Walmsley 2016) . A key factor in the growth of prison populations in Southeast Asia has been the costly and mainly ineffective BWar on Drugs^ (Csete et al. 2016) . In pursuit of a Bdrug free^Association of Southeast Asian Nations (ASEAN) by 2020, Member States have enacted some of the toughest drug laws in the world, including capital punishment for drug trafficking. Although mostly unsuccessful at reducing drug use (Crofts and Azim 2015) , these laws have increased rates of imprisonment among people who inject drugs (PWID), many of whom are HIV-infected Mathers et al. 2008 ) and have significant co-morbidity (Csete et al. 2016) , including substance use disorders and other mental illnesses (Zahari et al. 2010 ). These individuals, in turn, are at increased risk for HIV infection and concomitant opportunistic infections as a result of the immunosuppressant effects of HIV, including latent tuberculosis infection (LTBI) and rapid progression to active tuberculosis (TB). In Southeast Asia where HIV, TB, and addiction are syndemic, incarceration is also an independent risk factor for antiretroviral therapy (ART) nonadherence through disruptions in care (Milloy et al. 2011) , needle sharing and sexual risk behaviors that transmit HIV (Milloy et al. 2013) , and reduced lifespan (Patterson 2013) . Here, evidence from past and ongoing research is presented to address critical gaps and formulate key lessons for prevention and treatment of HIV, tuberculosis, and addiction within the Malaysian criminal justice system. We draw on our experiences in Malaysia, one of a few countries in Southeast Asia where HIV-related mortality, especially from TB, continues to increase despite reductions worldwide.
Substance use disorders, and especially drug injection, continue to play an important role in HIV transmission in Southeast Asia (Hser et al. 2016) , including countries with expanding epidemics like Malaysia and Indonesia, which are included in 16 countries where prevalence of drug injection, and HIV in PWID, are highest, yet prevention and treatment coverage including needle and syringe exchange programs (NSPs) and opioid agonist therapies (OAT) with methadone or buprenorphine are under-scaled (United Nations Office on Drugs and Crime (UNODC) 2014). Use of contaminated injection equipment by PWIDs provides an efficient vector for bloodborne infections, especially HIV and viral hepatitis. PWID are also at high risk for tuberculosis (TB), especially if HIV infected (Deiss et al. 2009 ). Asia has the world's highest TB burden (15 % of the global total) and 16 % of all HIV-infected TB cases globally (Joint United Nations Programme on HIV/AIDS (UNAIDS) 2013). Despite reductions in HIV incidence, morbidity and mortality (Joint United Nations Programme on HIV/ AIDS (UNAIDS) 2014b), such advances have not occurred similarly in PWID despite numerous evidence-based HIV prevention recommendations (Dutta et al. 2012 ; Joint United Nations Programme on HIV/AIDS (UNAIDS) 2014b). It is increasingly recognized that law enforcement strategies have failed to curb drug use (Irwanto et al. 2015) and contribute greatly to the risk of injection-related HIV infection (Booth et al. 2013; Ti et al. 2014) . Punitive drug policies including compulsory drug detention for PWID and the death penalty for drug trafficking, continue to be a direct barrier to evidencebased HIV prevention services for PWIDs in Southeast Asia, including access to needle and syringe programs and opioid agonist therapies (Irwanto et al. 2015 ; United Nations Office on Drugs and Crime (UNODC) 2014).
Repressive drug policies in many Asian countries have resulted in high rates of drug-related arrest, imprisonment of PWID and prison overcrowding, which have been counterproductive to HIV prevention and treatment (Jurgens et al. 2010) . Although some risk behaviors decrease during incarceration, both HIVand hepatitis C virus (HCV) transmission related to unsafe drug injection continues to occur among prisoners and detainees (Dolan et al. 2015) , often complicated by co-infection with TB (Biadglegne et al. 2015) . Unfortunately, few criminal justice settings offer comprehensive prevention or treatment services in spite of international guidelines that urge wide-ranging public health measures, including provision of OAT as an essential medication (World Health Organization (WHO) 
The HIV Epidemic in Malaysia
The HIV epidemic in Malaysia was initially concentrated in PWID, and HIV was therefore regarded by some public health officials and criminal justice authorities as a problem that would remain confined to PWID (Crofts and Azim 2015) . HIV quickly spread along drug trafficking routes in Southeast Asia (Beyrer et al. 2000) and began to enter other high-risk populations through sexual transmission. Although HIV prevalence in the general population (<0.5 %), indicates a concentrated epidemic similar to neighboring countries (Joint United Nations Programme on HIV/AIDS (UNAIDS) 2014c), much higher prevalence rates are observed in key populations including the estimated 205,000 (170,000-240,000) PWID ) of which 15.8 % (95%CI: 12.5 %-19.2 %) are HIV infected (Bazazi et al. 2015a ).
Malaysia has made significant progress in ensuring access to HIV testing. Of the estimated 105,000 (range: 91,000-110, 000) people living with HIV (PLH) in Malaysia, (Ministry of Health 2015), most (88.1 %) are already diagnosed, many as a result of mandatory HIV testing in criminal justice settings (Bazazi et al. 2015a ). Yet only 21,700 (21.7 %) of all PLH received antiretroviral therapy (ART) in 2014 (Joint United Nations Programme on HIV/AIDS (UNAIDS) 2014c) and ART coverage in PWID fails to reach even 5 % Wolfe et al. 2010 Our research with healthcare students and clinicians in Malaysia has generated compelling insights into the reasons behind Malaysia's HIV treatment gap. Recent surveys of medical students Jin et al. 2014 ) and physicians (Ferro et al. 2013 ) have identified stigmatizing attitudes and intentions to discriminate against members of key populations, including PWID and released prisoners, which could substantially reduce the number of PLH (even those with severely compromised immunity) who access care or receive treatment. Figure 1 shows results from a study of 214 ART-prescribing Malaysian physicians. When presented with hypothetical case scenarios, over half (53.3 %) indicated that they would defer ART for PWID, released prisoners, (or both), with markedly advanced (CD4 = 17cells/μL) HIV infection (Ferro et al. 2013) . Although the reasons why Malaysian physicians would defer ART for certain key populations are not clear, both stigmatizing attitudes toward prisoners and PWID, and unsubstantiated concerns about ART adherence may play roles.
The Tuberculosis Epidemic in Malaysia
Globally, there has been a 47 % reduction in tuberculosisrelated mortality since 1990 and TB incidence has dropped by 18 %, with nearly all improvements occurring since establishing the 2000 Millennium Development Goals (MDGs). Yet few countries have achieved MDGs for halving incidence, prevalence, and mortality by 2015 compared to 1990 figures. In 2014 alone, 9.6 million new TB cases were reported and TB killed~1.5 million (World Health Organization (WHO) 2015a). In 2014, there were an estimated 31,000 (25,000-37, 000) new TB cases in Malaysia, translating to 103 cases per 100,000 population, a number that has increased over the past decade. Low levels of community engagement (<2 %) to assist with TB treatment completion remains problematic. A case detection rate of 78 % (World Health Organization (WHO) 2015d), however, is in line with WHO targets and TB mortality (10/100,000) is generally lower than in neighboring countries like Thailand (18/100,000), Vietnam (20/ 100,000) or Indonesia (49/100,000). TB mortality rates are much higher in PLH than in those without HIV, attesting to delayed identification and provision of early ART after TB diagnosis (World Health Organization (WHO) 2015a). Of the estimated 3020 TB-related deaths in Malaysia, 620 (20 %) were among the approximately 105,000 PLH, for a crude TB-related mortality rate of 590 deaths per 100,000 PLH compared to 8 deaths per 100,000 in the HIVuninfected adult population.
The Criminal Justice System in Malaysia
Since 2000, Malaysia's drug policies have resulted in substantial increases (45 %) in its incarceration rate from 116 to 171 per 100,000, with a total of 51,946 persons incarcerated in 39 prisons and pre-trial detention centers nation-wide (Walmsley 2016) . Overcrowding is common with many facilities operating at or above designed occupancy capacity (Institute for Criminal Policy Research 2015). HIV testing is mandatory upon entry and HIV-infected prisoners (~4.8 % of sentenced prisoners) are segregated in special housing units, elevating the risk of explosive TB outbreaks (McLaughlin et al. 2003; Spradling et al. 2002; Valway et al. 1994) , and reinforcing the stigmatization of HIV in the prison setting. Our team has documented high levels of psychiatric comorbidity (Zahari et al. 2010) , substance use (Choi et al. 2010 ) and infectious diseases (Al-Darraji et al. 2014a; Al-Darraji et al. 2013; Bachireddy et al. 2011; Bick et al. 2013; Margolis et al. 2013; Wickersham et al. 2013b ) in Malaysian prisoners, especially those with HIV, yet healthcare resources, including trained medical staff, are inadequate to address the health needs of prisoners.
In addition to drug laws that crowd PWID into jails and prisons, PWID in Malaysia are often forcibly placed into compulsory drug detention centers (CDDC) known as PUSPEN. These centers were enacted as part of the 1952 Dangerous Drugs Act and 1983 Drug Dependence (Treatment and Rehabilitation) Act, to detain people who test positive for drugs for a mandatory two-year period without due process and against their will (Gill et al. 2010; Kamarulzaman 2009b) . CDDCs in Malaysia and other Southeast Asian countries have been criticized for a variety of human rights violations (Amon et al. 2013; Amon et al. 2014; Pearshouse and Amon 2012) , including indefinite detention, physical abuse and torture of detainees (Amon et al. 2013; Amon et al. 2014) , and the denial or inadequate provision of medical care including evidencebased addiction treatment despite high prevalence of substance use disorders among detainees (Fu et al. 2012; Tanguay 2011; Tanguay et al. 2015) . Despite international criticism, the number of CDDCs has continued to increase in East and Southeast Asia (Tanguay et al. 2015 ; United Nations Office on Drugs and Crime (UNODC) 2010a; b). By 2012, over 235,000 people were detained in over a thousand CDDCs (Lewis 2012) , including 6658 individuals detained in 28 CDDCs in Malaysia (Fu et al. 2012 ).
In 2012, however, a plan began to transform many CDDCs in Malaysia to voluntary treatment clinics that provide methadone treatment (Al-Darraji et al. 2014b) known as Cure & Care Clinics (Tanguay et al. 2015) . Part of this transformation occurred as a result of research showing that CDDCs did not effectively treat addiction, with relapse rates exceeding 70 % to 90 % within a year (UNODC 2010a, b), and did not provide healthcare (Fu et al. 2012) . Consequently, several United Nations agencies called for their immediate closure (Amon et al. 2013; Amon et al. 2014) due to a lack of evidencedbased addiction treatment and medical care including for HIV and TB (Fu et al. 2012) . Recent data from Malaysia suggest that transforming CDDCs to voluntary treatment centers is feasible, acceptable to patients, provides evidence-based treatments, attracts patients who might not be involved with the criminal justice system (Ghani et al. 2015; Khan et al. 2015; Krishnan et al. 2016) , and is markedly more effective in reducing illicit opioid relapse (Wegman et al., under review) . Nevertheless, the question of whether to maintain CDDCs remains contentious and, for as long as the drug laws and policies remain as they are, criminalization will continue to be the mainstay of the response despite the progress of public health interventions in recent years. , and remain an important focus of interventions to control the spread of HIV. In Malaysia, many PWID continue to engage in multiple high-risk behaviors that span diverse social networks (Bazazi et al. 2015a ) although access to harm reduction services and opioid-agonist therapy (OAT) to treat addiction appears limited, and prevalence of non-fatal overdose is correspondingly high (Bazazi et al. 2015b) . As a mobile population disproportionately subject to imprisonment, PWID face formidable barriers to HIV prevention and treatment services (Milloy et al. 2012) , despite high prevalence of comorbidities including HCV-and alcoholrelated liver disease (Larney et al. 2013) , and AIDS-and non-AIDS related death (Mathers and Degenhardt 2014) .
After decades of deploying a strictly punitive approach toward PWID, Malaysia introduced evidence-based harm reduction programs in 2006, including needle and syringe programs (NSPs) and opioid agonist therapies (OAT) with methadone (Kamarulzaman 2009a) . Buprenorphine therapy was introduced in 2002, but its expansion was undermined by buprenorphine diversion and negative unanticipated health consequences (Bruce et al. 2008; Bruce et al. 2009 ). Supported primarily by the Ministry of Health and the Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM), NSPs have been implemented in all states in peninsular Malaysia (Malaysian AIDS Council, Malaysian AIDS Foundation 2014). Methadone was expanded through a threephase program within 1) addiction specialty clinics; 2) primary care clinics; and then 3) prisons (Noordin et al. 2008; Wickersham et al. 2013a; Wickersham et al. 2013b ). The National Anti-Drug Agency (AADK), which is also responsible for CDDCs, also increased voluntary addiction treatment units that provide methadone in some former CDDCs (AlDarraji et al. 2014b; Degenhardt et al. 2014; Fu et al. 2012; Ghani et al. 2015) .
Nevertheless, many challenges and barriers remain in terms of sustaining and scaling up OAT for PWID. For example, law enforcement practices, including surveillance and arrest of clients receiving methadone and accessing NSPs in the community, are not aligned with the aims of harm reduction. Also, more work remains to be done to address persistent negative stereotypes, for example, the notion that methadone represents another form of addiction, and discrimination against patients enrolled in methadone treatment programs and NSPs (Beg et al. 2015) . Among PWID in the community, low levels of treatment readiness and ongoing use of buprenorphine and methadone outside of treatment settings, could undermine acceptance for OAT despite awareness of its efficacy (Bachireddy et al. 2011; Vijay et al. 2015) . Also, the market for synthetic drugs and amphetamine type stimulants in Asia is large and expanding (United Nations Office on Drugs and Crime (UNODC) 2013b). OAT may not have the same benefits for persons who are exclusively dependent upon or engaged in risk behaviors related to methamphetamine, which can adversely influence ART adherence (Moore et al. 2012) , and contribute to high-risk sexual behaviors and HIV transmission, especially among men who have sex with men (Hser et al. 2016 ).
Incarceration of People Who Inject Drugs in Malaysia
Malaysia's punitive drug laws have resulted in high rates of incarceration among PWID. In a sample of 461 PWID in Kuala Lumpur, 53.5 % (95 % CI: 48.9 % -58.0 %) had a lifetime history of incarceration, and 61.5 % (95 % CI: 57.2 % -65.9 %) had been detained in CDDCs. Within the previous 6 months, 44.1 % (95%CI: 39.6-48.7) had been in jail, 13.9 % (95 % CI: 10.9 % -17.2 %) had been to prison, and 3.1 % (95 % CI: 1.5-4.8 %) had been detained in a CDDC (Bazazi et al. 2015b; Vijay et al. 2015) . Incarceration of PWID (many of whom are HIV-infected and medically underserved) results in an ethical and legal mandate to provide necessary and decent care (Lines 2008) including the following evidence-based interventions: 1) access to condoms and deterrents to sexual assault; 2) needle and syringe programs; 3) bleach and decontamination strategies; and 4) OAT as part of addiction treatment (Jürgens et al. 2009 ; United Nations Office on Drugs and Crime (UNODC) 2012; United Nations Office on Drugs and Crime (UNODC) 2013a).
Unfortunately, very few prisons offer comprehensive HIV prevention services, and even when they are offered, social and environmental conditions within prisons are often extremely counterproductive to treating HIV or addiction. For example, although OAT programs have been implemented in prisons in at least 29 countries (Larney and Dolan 2009 ), including Malaysia, addiction treatment services may reach only a small number of prisoners who need them. This is in part because methadone may be stigmatized within a prison subculture where drug use and high-risk drug injection are prevalent and accepted (Polonsky et al. 2016a, b) , and prisoners spend large parts of their day finding, paying for, and using drugs (Culbert et al. 2015) . In fact, a main benefit of OAT identified by Australian prisoners, is the financial advantage of not buying drugs in prison (Sindicich et al. 2016) . Similarly, in Malaysia where 95 % of HIV-infected male prisoners meet criteria for opioid dependence and twothirds (66 %) shared needles immediately before incarceration (Bachireddy et al. 2011 ), very few had used methadone (3.9 %). Especially damaging were prisoner's perceptions that heroin and methadone represent different forms of addiction, which has been documented among HIV-infected prisoners in Malaysia (Choi et al. 2010) and Indonesia (Culbert et al. 2015) . Such attitudes also exist in countries like Ukraine and Moldova where OAT was introduced a decade ago, at a similar time to Malaysia. Reasons for negative attitudes toward OAT in prisons are complex and may be related to negatives attitudes perpetuated by prison personnel (Polonsky et al. 2015) , opposition to OAT by persons tied to the prison drug economy (Polonsky et al. 2016a) , the misperception that addiction is not a chronic and recurring illness (Polonsky et al. 2016a; Polonsky et al. 2016b) , or the belief that OAT is not effective (Bachireddy et al. 2011; Mukherjee et al. 2016) . In Malaysia, such negative attitudes toward OAT as an effective treatment for opioid addiction persist among PWID in the community as well (Vijay et al. 2015) .
Addressing HIV, Tuberculosis, and Opioid Addiction in Prisoners
In Malaysia, prison-based OAT was initiated through pilot programs in two prisons in 2008-2009 and now reaches about 250 prisoners (Wickersham et al. 2013a; Wickersham et al. 2013b ). These programs developed from evidence that provision of OAT during incarceration and after release to the community was associated with significantly improved postrelease health outcomes in PLH (Gordon et al. 2011; Kinlock et al. 2009 ), and so initially targeted PLH within the prison setting. Prior to introducing methadone maintenance therapy (MMT) at these sites, we conducted a formative assessment, which suggested a number of important implementation barriers, including undesirable methadone side effects, lack of physician training, and law enforcement practices that interfered with methadone treatment in released prisoners (Wickersham et al. 2013a) . One of the most important lessons to emerge was that patients who were released on a daily methadone dose >80 mg were more likely to be retained on methadone 1 year after release (Wickersham et al. 2013b ). This turned our attention to the importance of optimizing MMT dose and addressing cravings and side effects prior to and during community re-entry -a period accurately perceived by prisoners as high risk for drug relapse (Cepeda et al. 2015b; Choi et al. 2010 ) and risk behaviors (Cepeda et al. 2015a) .
Equipped with these insights, we embarked on a study in 2011, Project HARAPAN, to evaluate (through a randomized controlled trial) the relative effectiveness of methadone maintenance therapy alone, and in combination with a behavioral intervention (Holistic Health Recovery Program, HHRP) for reducing HIV risk behaviors and drug use in HIV-infected, opioiddependent Malaysian prisoners. In the process of adapting HHRP to the Malaysian context (HHRP-M), we learned that HIV status disclosure, social support, and accessing ART after release were seen by prisoners as especially challenging and therefore adapted HHRP to address the knowledge and interpersonal skills needed to successfully access care and negotiate safer sex, harm reduction, and HIV status disclosure during the immediate post-release period (Copenhaver et al. 2011) .
It also became apparent that HIV-related mortality within prison was extraordinarily high. During the first two years of Project HARAPAN alone, there were 28 HIV-related deaths within a single prison, with some participants not surviving long enough to receive the methadone/HHRP intervention. Closer examination revealed large gaps in HIV treatment and a lack of clinical resources and healthcare staffing allocated to address the high burden of illness in HIV+ prisoners. For example, although HIV testing was mandatory, which does not conform to international recommendations (United Nations Office on Drugs and Crime (UNODC) 2009), subsequent linkage to HIV treatment and care failed to meet clinical or ethical standards (Basu et al. 2005) , with less than half (48.4 %) of eligible HIV+ prisoners receiving ART (Bick et al. 2013) . To address these gaps in care, our team established an HIV subspecialty clinic within Malaysia's largest prison in September 2012, with staffing from the University of Malaya and Yale University. The clinicians worked alongside the existing prison doctors, introduced routine CD4 testing and monitoring, and provided ART in close accordance with Malaysian Ministry of Health guidelines (CD4 < 350 cells/ μL). As a result, we saw a 50 % decline in all-cause mortality from 2010 to 2014 (see Fig. 2 ), and HIV-related deaths were reduced 75.7 % over the same period from an average of 14.3 deaths annually from 2010 to 2012, to 3.5 deaths annually from 2013 to 2014. As a proportion of all deaths, HIV-related deaths declined 95 % from 2010-12 to 2013-14.
Tuberculosis in prisoners in Malaysia, especially those with HIV, remains problematic. Screening studies for LTBI in a variety of prisons (see Fig. 3 ), including those housed in closed dormitories (Al-Darraji et al. 2014a) as well as those with open-air housing conditions (Margolis et al. 2013) , show the prevalence of LTBI to exceed 80 %, with prevalence being higher in those without HIV, likely due to the immunosuppressant effects of HIV and inability to respond to tuberculin skin testing (TST). Additional data suggest that the prevalence of LTBI in PWIDs in community settings is similar to that reported in prisons, through which many PWID had previously transitioned, suggesting that prisons are extraordinary amplifiers of TB (Al-Darraji et al. 2014b) . Also confirming the high risk environment for TB in prisons is the finding that correctional officers and other personnel who work in the prison, regardless of the amount of time spent in the prison setting, had a prevalence of LTBI similar to that of prisoners (AlDarraji et al. 2015) . The prevalence of LTBI in prisoners (88.8 %) and prison personnel (81.0 %), however, was much higher than in Southeast Asia (46.0 %) or the Western Pacific (32.0 %), or even among Malaysian healthcare workers (52.1 %) (Rafiza et al. 2011 ). Not only is LTBI infection high, but using standard screening strategies with symptoms and sputum tested for TB using AFB smear, GeneXpert and culture, 17.9 % of 134 HIV-infected prisoners had TB disease; 15 (12.0 %) of the 125 without previously known TB were newly diagnosed. Important from this screening study is that the WHO-recommended symptom surveys and GeneXpert MTB/RIF with a single sputum examination sub-optimally identified MTB cases .
Confronting the Perfect Storm
The convergence of the HIV, tuberculosis (TB), and addiction epidemics in populations that are overwhelmingly exposed to incarceration and its negative long-term health effects (Patterson 2013) will drastically increase the magnitude of harm and costs associated with these epidemics to individuals and communities. Confronting this 'perfect storm' requires stakeholders to prioritize evidence-based strategies to reduce the consequences to individuals and communities (El-Bassel et al. 2013 ). This will be especially crucial for Malaysia to meet the 2020 UNAIDS 90-90-90 goals to ensure 90 % of PLH are diagnosed, with 90 % of these on ART and 90 % of ART patients achieving viral suppression. This translates to viral suppression rates exceeding 73 % (Joint United Nations Programme on HIV/AIDS 2014a).
Although the use of incarceration as a drug control measure has failed to stem rates of addiction in the community (Irwanto et al. 2015) and arguably exacerbated problems associated with A recent systematic review suggested that the period immediately after release from prison is when ART linkage is least successful and results in sustained treatment interruptions (Iroh et al. 2015) , but is mitigated in PLH receiving OAT with methadone or buprenorphine (Springer et al. 2010; Springer et al. 2012; Wickersham et al. 2013b) , especially with adequately high doses. Initiating ART and OAT within prison would begin to address low rates of ART coverage in PWID and, coupled with effective transitional care, be especially crucial for ensuring viral suppression during community re-entry (Springer et al. 2011 ). Last, because TB is so prevalent in prisoners and has devastating consequences when HIV patients are congregated, morbidity and mortality could be reduced further by removing segregation policies, implementing standardized screening programs for TB, promptly isolating those with suspected and confirmed contagious TB, and initiating treatment for those with active disease and isoniazid preventive therapy (IPT) for those with LTBI (Granich et al. 2010; Theron et al. 2011 ; World Health Organization (WHO) 2011). Continuation of treatment for TB and LTBI would also be optimized by integrating OAT with TB treatments (Getahun et al. 2013; Morozova et al. 2013 ; United Nations Office on Drugs and Crime (UNODC) 2006; WHO/UNODC/UNAIDS 2008), similar to recommendations for ART. This is especially true since 67 % of patients identified with either active or LTBI infection have inadequate time remaining on their prison sentence to complete treatment and therefore need effective transitional care (Al-Darraji et al. 2016) . Together, these interventions will forestall the negative consequence of the perfect storm and promote individual and public health.
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